AC BioScience is a biotech start-up with a unique business plan and ambition. We’re committed to finding novel ways to treat a variety of malignancies. The business is driving a paradigm change in cancer therapies, founded by Andreas Schläpfer and Professor Christian Auclair, an internationally recognised expert in molecular oncology. The EPFL Innovation Park near Lausanne is where the company is based, and it celebrated its first anniversary in March 2018.
$ 1 Million - $ 2.5 Millions